X @Bloomberg

Market Dynamics - Eli Lilly and Novo Nordisk secured deals with the Trump administration [1] - The deals involve slashing prices for their blockbuster weight-loss drugs [1] - The deals are in exchange for tariff relief and wider access for Medicare patients [1]